#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3264	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2527	383.0	0	.	n	.	0	A69G	SNP	69	69	A	444	444	G	444	G,A	257,106	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3264	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2527	383.0	0	.	n	.	0	C1450T	SNP	1450	1450	C	1825	1825	T	470	T	384	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3264	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2527	383.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1559	1559	C	521	C,T	417,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3264	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2527	383.0	0	HET	.	.	.	C207T	.	207	207	C	582	582	C	450	C,T	244,108	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5158	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3887	397.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1816	1816	A	392	A,G	318,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5158	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3887	397.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2450	2450	C	525	C,A,T	415,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5158	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3887	397.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2524	2524	A	547	A	439	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5158	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3887	397.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3076	3076	C	485	C,A	382,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_U_01433c	folP.WHO_U_01433c	1	1	539	446	folP	852	852	99.88	folP.l6.c4.ctg.1	1853	71.8	0	.	p	.	0	E151K	NONSYN	451	453	GAA	924	926	AAA	97;97;98	A,C;A;A,C	79,1;78;79,1	.	.
folP.WHO_U_01433c	folP.WHO_U_01433c	1	1	539	446	folP	852	852	99.88	folP.l6.c4.ctg.1	1853	71.8	1	SNP	p	R228S	1	.	.	682	684	AGC	1155	1157	AGC	88;88;87	A;G;C	71;76;74	folP.WHO_U_01433c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	960	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3762	76.4	1	SNP	p	S91F	0	.	.	271	273	TCC	792	794	TCC	86;86;85	T;C;C	64;69;68	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	960	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3762	76.4	1	SNP	p	D95G	0	.	.	283	285	GAC	804	806	GAC	86;86;86	G,T;A;C	63,1;66;68	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	960	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3762	76.4	1	SNP	p	D95N	0	.	.	283	285	GAC	804	806	GAC	86;86;86	G,T;A;C	63,1;66;68	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	416	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1618	76.5	1	SNP	p	G45D	0	.	.	133	135	GGC	596	598	GGC	114;114;114	G;G;C	92;89;92	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	206	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1417	43.6	0	.	n	.	0	A197.	DEL	197	197	A	807	807	A	100	A	75	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1066	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3272	97.3	1	SNP	p	D86N	0	.	.	256	258	GAC	702	704	GAC	99;99;98	G,C;A;C	77,1;80;80	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1066	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3272	97.3	1	SNP	p	S87I	0	.	.	259	261	AGT	705	707	AGT	99;101;101	A,G;G;T	72,1;76;76	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1066	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3272	97.3	1	SNP	p	S87R	0	.	.	259	261	AGT	705	707	AGT	99;101;101	A,G;G;T	72,1;76;76	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1066	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3272	97.3	1	SNP	p	S87W	0	.	.	259	261	AGT	705	707	AGT	99;101;101	A,G;G;T	72,1;76;76	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1066	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3272	97.3	1	SNP	p	S88P	0	.	.	262	264	TCC	708	710	TCC	100;101;101	T,G,C;C;C	77,1,1;80;77	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	854	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3095	82.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1768	1770	GGC	116;115;115	G;G;C	99;98;97	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	844	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2556	98.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1304	1306	GCA	120;123;122	G;C;A	89;91;93	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	844	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2556	98.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1307	1309	ATC	122;121;123	A;T,G;C	91;89,1;93	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	844	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2556	98.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1319	1321	GTG	122;123;123	G;T;G	95;91;93	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	844	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2556	98.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1319	1321	GTG	122;123;123	G;T;G	95;91;93	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	844	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2556	98.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1823	1825	ACC	92;93;93	A;C;C,A	76;79;75,1	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	844	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2556	98.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1877	1879	GCG	95;94;93	G;C,A,G;G	73;65,1,1;65	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	844	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2556	98.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1877	1879	GCG	95;94;93	G;C,A,G;G	73;65,1,1;65	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	844	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2556	98.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2000	2002	GGC	93;92;92	G;G;C	77;76;79	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	844	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2556	98.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2009	2011	GGC	92;92;91	G;G;C	80;78;77	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	844	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2556	98.1	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2027	2029	CTG	99;99;101	C;T,C;G	80;75,2;80	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1166	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3426	101.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1841	1843	CCG	98;99;99	C;C;G,T	71;72;74,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	488	porA	1146	1146	99.65	porA.l6.c4.ctg.1	2169	67.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	815	815	C	75	C	64	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	74	porB1a	984	297	90.37	porB1a.l15.c30.ctg.1	1103	16.0	0	.	p	.	0	H217N	NONSYN	649	651	CAT	829	831	AAT	16;16;16	A;A;T	13;14;14	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	74	porB1a	984	297	90.37	porB1a.l15.c30.ctg.1	1103	16.0	0	.	p	.	0	D218N	NONSYN	652	654	GAT	832	834	AAT	16;16;16	A;A;T	14;13;14	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	74	porB1a	984	297	90.37	porB1a.l15.c30.ctg.1	1103	16.0	0	.	p	.	0	V226A	NONSYN	676	678	GTA	856	858	GCA	16;16;16	G;C;A	14;13;14	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	74	porB1a	984	297	90.37	porB1a.l15.c30.ctg.1	1103	16.0	0	.	p	.	0	.	MULTIPLE	700	702	ACT	879	881	GTA	15;15;15	G;T;A	12;13;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	74	porB1a	984	297	90.37	porB1a.l15.c30.ctg.1	1103	16.0	0	.	p	.	0	S236N	NONSYN	706	708	AGC	885	887	AAC	15;15;15	A;A;C	12;13;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	74	porB1a	984	297	90.37	porB1a.l15.c30.ctg.1	1103	16.0	0	.	p	.	0	.	MULTIPLE	709	711	AAC	889	893	TGGCG	14;14;14;14;14	T;G;G;C;G	12;12;11;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	74	porB1a	984	297	90.37	porB1a.l15.c30.ctg.1	1103	16.0	0	.	p	.	0	D238A	NONSYN	712	714	GAT	895	897	GCT	13;13;13	G;C;T	12;12;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	74	porB1a	984	297	90.37	porB1a.l15.c30.ctg.1	1103	16.0	0	.	p	.	0	V258L	NONSYN	772	774	GTA	955	957	TTA	15;15;15	T;T;A	12;12;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	74	porB1a	984	297	90.37	porB1a.l15.c30.ctg.1	1103	16.0	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	1000	1002	CAT	19;19;19	C;A;T	12;12;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	74	porB1a	984	297	90.37	porB1a.l15.c30.ctg.1	1103	16.0	0	.	p	.	0	D274S	NONSYN	820	822	GAT	1003	1005	AGT	19;19;19	A;G;T	11;12;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	74	porB1a	984	297	90.37	porB1a.l15.c30.ctg.1	1103	16.0	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	1012	1014	TAC	19;19;19	T;A;C	12;12;12	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	680	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1850	108.3	0	.	p	.	0	N38E	NONSYN	112	114	AAT	585	587	GAA	156;155;156	G,C;A;A	112,1;118;118	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	680	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1850	108.3	0	.	p	.	0	N134D	NONSYN	400	402	AAT	873	875	GAT	105;105;105	G,T;A;T	85,1;85;85	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	680	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1850	108.3	0	.	p	.	0	P175S	NONSYN	523	525	CCA	996	998	TCA	128;127;127	T,A;C;A	103,1;108;108	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	680	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1850	108.3	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1125	1127	GTC	147;146;145	G,A,T;T;C	110,1,1;109;112	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	680	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1850	108.3	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1137	1139	TCT	148;148;149	T,A;C,T;T	113,1;112,1;117	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	680	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1850	108.3	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1455	1457	GCA	158;159;154	G;C,A;A	130;130,1;128	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	680	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1850	108.3	1	SNP	p	G120K	1	.	.	358	360	AAG	831	833	AAG	116;115;115	A,C;A;G	93,1;95;96	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	680	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1850	108.3	1	SNP	p	A121D	1	.	.	361	363	GAC	834	836	GAC	115;115;114	G;A;C	92;92;90	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	680	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1850	108.3	1	SNP	p	D121N	0	.	.	361	363	GAC	834	836	GAC	115;115;114	G;A;C	92;92;90	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	2532	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5202	145.6	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2210	2212	AAT	149;149;147	A;A;T,G	117;115;113,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	346	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1265	81.6	1	SNP	p	V57M	1	.	.	169	171	ATG	660	662	ATG	144;144;145	A;T;G	123;126;123	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
